Your browser doesn't support javascript.
loading
Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial.
Mesa, Ruben A; Vannucchi, Alessandro M; Mead, Adam; Egyed, Miklos; Szoke, Anita; Suvorov, Aleksandr; Jakucs, Janos; Perkins, Andrew; Prasad, Ritam; Mayer, Jiri; Demeter, Judit; Ganly, Peter; Singer, Jack W; Zhou, Huafeng; Dean, James P; Te Boekhorst, Peter A; Nangalia, Jyoti; Kiladjian, Jean-Jacques; Harrison, Claire N.
Afiliação
  • Mesa RA; Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ, USA. Electronic address: mesa.ruben@mayo.edu.
  • Vannucchi AM; Center of Research and Innovation of Myeloproliferative Neoplasms, Department of Experimental and Clinical Medicine, AOU Careggi and University of Florence, Florence, Italy.
  • Mead A; Clinical Haematology, NIHR Biomedical Research Centre, Churchill Hospital, Oxford, UK.
  • Egyed M; Department of Hematology, Somogy County Kaposi Mor Hospital, Kaposvar, Hungary.
  • Szoke A; Second Department of Internal Medicine and Cardiology Center, Albert Szent-Györgyi Clinical Center, University of Szeged, Szeged, Hungary.
  • Suvorov A; First Republican Clinical Hospital of Udmurtia, Izhevsk, Russia.
  • Jakucs J; Békés Megyei Pándy Kálmán Kórház, Gyula, Hungary.
  • Perkins A; ICON Cancer Care, South Brisbane, QLD, Australia.
  • Prasad R; Royal Hobart Hospital, Hobart, Australia.
  • Mayer J; Department of Internal Medicine, University Hospital Brno, Brno, Czech Republic.
  • Demeter J; First Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
  • Ganly P; Department of Haematology, Christchurch Hospital, Christchurch, New Zealand.
  • Singer JW; CTI BioPharma Corp, Seattle, WA, USA.
  • Zhou H; CTI BioPharma Corp, Seattle, WA, USA.
  • Dean JP; CTI BioPharma Corp, Seattle, WA, USA.
  • Te Boekhorst PA; Erasmus Medical Center, Rotterdam, Netherlands.
  • Nangalia J; Wellcome Trust Sanger Instutite, Hinxton, UK.
  • Kiladjian JJ; Centre d'Investigations Cliniques, APHP, Hôpital Saint-Louis, INSERM CIC 1427, Paris, France; Paris Diderot University, Paris, France.
  • Harrison CN; Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Lancet Haematol ; 4(5): e225-e236, 2017 May.
Article em En | MEDLINE | ID: mdl-28336242
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pancitopenia / Pirimidinas / Baço / Hidrocarbonetos Aromáticos com Pontes / Mielofibrose Primária Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pancitopenia / Pirimidinas / Baço / Hidrocarbonetos Aromáticos com Pontes / Mielofibrose Primária Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article